Newlink Genetics Cor (NLNK) Stock Price, Forecast & Analysis

NASDAQ:NLNK

0.89
-0.13 (-12.75%)
Last: Mar 18, 2020, 08:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News

NLNK Key Statistics, Chart & Performance

Key Statistics
Market Cap33.22M
Revenue(TTM)936.00K
Net Income(TTM)-42.99M
Shares37.33M
Float26.80M
52 Week High3.6
52 Week Low0.82
Yearly Dividend0
Dividend Yield0%
EPS(TTM)-1.03
PEN/A
Fwd PEN/A
Earnings (Next)N/A
IPON/A
Sector
GICS SectorN/A
GICS IndustryN/A
GICS IndustryGroupN/A
GICS SubIndustryN/A
NLNK short term performance overview.The bars show the price performance of NLNK in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -10 -20 -30 -40 -50

NLNK long term performance overview.The bars show the price performance of NLNK in the last 1, 2 and 3 years. 1 year 2 years 3 years -10 -20 -30 -40 -50

The current stock price of NLNK is 0.89 null. In the past month the price decreased by -43.67%. In the past year, price decreased by -53.4%.

Newlink Genetics Cor / NLNK Daily stock chart

NLNK Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating
NLNK Full Technical Analysis Report

NLNK Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to NLNK. NLNK scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
NLNK Full Fundamental Analysis Report

NLNK Financial Highlights

Over the last trailing twelve months NLNK reported a non-GAAP Earnings per Share(EPS) of -1.03. The EPS increased by 28.47% compared to the year before.


Industry RankSector Rank
PM (TTM) -4592.84%
ROA -44.42%
ROE N/A
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%21.43%
Sales Q2Q%114.36%
EPS 1Y (TTM)28.47%
Revenue 1Y (TTM)-92.5%
NLNK financials

NLNK Forecast & Estimates


Analysts
Analysts60
Price TargetN/A
EPS Next Y78.64%
Revenue Next YearN/A
NLNK Analyst EstimatesNLNK Analyst Ratings

NLNK Ownership

Ownership
Inst Owners32.32%
Ins Owners22.34%
Short Float %N/A
Short RatioN/A
NLNK Ownership

About NLNK

Company Profile

NewLink Genetics Corporation is a biopharmaceutical company which focuses on discovering, developing and commercializing immunotherapeutic products for cancer treatment. Its portfolio also includes biologic and small-molecule immunotherapy products used for the treatment of oncology indications. NewLink Genetics Corporation is headquartered in Ames, Iowa.

Company Info

Newlink Genetics Cor

2503 SOUTH LOOP DRIVE

AMES IA 50010

CEO: Carl W. Langren

Phone: 515-296-5555

Newlink Genetics Cor / NLNK FAQ

Can you describe the business of Newlink Genetics Cor?

NewLink Genetics Corporation is a biopharmaceutical company which focuses on discovering, developing and commercializing immunotherapeutic products for cancer treatment. Its portfolio also includes biologic and small-molecule immunotherapy products used for the treatment of oncology indications. NewLink Genetics Corporation is headquartered in Ames, Iowa.


What is the current price of NLNK stock?

The current stock price of NLNK is 0.89 null. The price decreased by -12.75% in the last trading session.


What is the dividend status of Newlink Genetics Cor?

NLNK does not pay a dividend.


How is the ChartMill rating for Newlink Genetics Cor?

NLNK has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.


Where is Newlink Genetics Cor (NLNK) stock traded?

NLNK stock is listed on the Nasdaq exchange.